Free Trial

AdvanSix Inc. (NYSE:ASIX) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

AdvanSix logo with Basic Materials background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in AdvanSix Inc. (NYSE:ASIX - Free Report) by 29.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 71,279 shares of the company's stock after acquiring an additional 16,078 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.27% of AdvanSix worth $2,031,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. AlphaQuest LLC purchased a new position in shares of AdvanSix in the 4th quarter valued at about $94,000. KLP Kapitalforvaltning AS acquired a new position in AdvanSix in the 4th quarter worth about $137,000. State of Wyoming acquired a new position in AdvanSix in the 4th quarter worth about $156,000. BOKF NA acquired a new position in AdvanSix in the 4th quarter worth about $217,000. Finally, ProShare Advisors LLC acquired a new position in AdvanSix in the 4th quarter worth about $220,000. Institutional investors and hedge funds own 86.39% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on ASIX shares. Wall Street Zen upgraded AdvanSix from a "buy" rating to a "strong-buy" rating in a research note on Saturday, May 31st. UBS Group set a $35.00 price objective on AdvanSix in a research note on Tuesday, March 18th. Finally, Piper Sandler set a $32.00 price objective on AdvanSix in a research note on Monday, May 19th.

Check Out Our Latest Research Report on AdvanSix

AdvanSix Trading Up 0.8%

AdvanSix stock traded up $0.20 during midday trading on Wednesday, reaching $24.80. 137,977 shares of the stock traded hands, compared to its average volume of 152,879. The company has a 50-day simple moving average of $22.30 and a two-hundred day simple moving average of $26.27. AdvanSix Inc. has a 12-month low of $18.44 and a 12-month high of $33.00. The firm has a market cap of $664.91 million, a PE ratio of 15.40 and a beta of 1.62. The company has a current ratio of 1.08, a quick ratio of 0.49 and a debt-to-equity ratio of 0.25.

AdvanSix Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 2.58%. The ex-dividend date of this dividend was Tuesday, May 13th. AdvanSix's payout ratio is currently 20.51%.

Insider Activity

In related news, SVP Achilles B. Kintiroglou sold 4,000 shares of the firm's stock in a transaction dated Tuesday, April 1st. The stock was sold at an average price of $22.24, for a total transaction of $88,960.00. Following the transaction, the senior vice president now owns 36,363 shares of the company's stock, valued at $808,713.12. This trade represents a 9.91% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 5.60% of the company's stock.

About AdvanSix

(Free Report)

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.

Further Reading

Institutional Ownership by Quarter for AdvanSix (NYSE:ASIX)

Should You Invest $1,000 in AdvanSix Right Now?

Before you consider AdvanSix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdvanSix wasn't on the list.

While AdvanSix currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines